Headlines

The Court of Chancery of the State of Delaware issued a preliminary injunction delaying a shareholder vote on Qualcomm Incorporated's proposed acquisition of Atheros Communications, Inc. for approximately $3.1 billion.

The FDA has new data showing that the migraine and anti-seizure drug Topamax (Topiramate) may increase the risk of birth defects in babies born to women who took the medication while pregnant.

On March 4, 2011, the Food and Drug Administration (FDA) issued a Class I recall of Davol, Inc.'s XenMatrix Surgical Graft, a device used in hernia and abdominal wall repair.

The Journal of the American Medical Association (JAMA) published a study that concludes bisphosphonate use nearly triples the risk of drug-related femur fractures in patients who have taken the drug for more than five years.

In a Feb. 8, 2011, news release, the FDA announced its proposed Innovative Pathway initiative, designed to shorten the FDA approval process for "new, breakthrough medical devices."

Since being appointed to manage BP's $20 billion oil spill compensation fund, Kenneth Feinberg has received criticism from claimants and politicians regarding the Gulf Coast Claims Facility (GCCF) process. Now, BP is publicly chastising Feinberg for proposing settlements that it believes to be overly charitable.

The military has agreed to identify ways to protect deployed service members from potentially toxic burn pit fumes and smoke.

Attorney Marlon Kimpson will be speaking at the Texas Association of Public Employee Retirement Systems (TEXPERS) 22nd annual conference.

ABC News reported on the safety risks linked to pilots who fly long hours without an adequate amount of sleep.

On Wednesday, Feb. 2, 2011, Administrator of the Gulf Coast Claims Facility (GCCF) Kenneth Feinberg announced new proposed criteria that the GCCF plans to use moving forward.